Comparing Traditional Dialysis Industry Segments with Novel Pharmacological Product Types and Gene Therapy Specific Technologies
For decades, the final stage of polycystic kidney disease was almost inevitably managed by dialysis or transplantation. These industry segments are highly resource-intensive and represent a significant burden on both patients and healthcare budgets. However, we are currently entering an era where the primary goal of nephrology is to delay the onset of end-stage renal disease for as long as...
0 Σχόλια 0 Μοιράστηκε 339 Views 0 Προεπισκόπηση